Home >
Medicine Info >
Nucarnit-E 150 mg Capsule
Loading interface...

Nucarnit-E 150 mg Capsule

Manufactured byEmcure Pharmaceuticals Ltd.
ContainsLevocarnitine
Description
Nucarnit-E 150 mg Capsule is a naturally occurring substance in the body that facilitates the conversion of fat to energy. Nucarnit-E 150 mg Capsule is used to treat severe carnitine deficiency. Carnitine is a protein that is made in your brain, liver, and kidneys. It helps the body in the conversion of fat into energy. This medicine is also used for the treatment of secondary carnitine deficiency (when there is not enough carnitine in the blood). Nucarnit-E 150 mg Capsule works by increasing the levels of carnitine in the body. Nucarnit-E 150 mg Capsule may cause side effects like nausea, vomiting, pain, swelling and redness at the injection site, headache, etc. Seek medical attention if these side effects persist. Avoid taking Nucarnit-E 150 mg Capsule if you are allergic to it. Nucarnit-E 150 mg Capsule can be used in children only if advised by your doctor. Nucarnit-E 150 mg Capsule is available as tablet, capsule, oral solution and injection dosage forms. The dose of the medicine and duration of treatment will be decided by your doctor based on your condition. The oral form of Levocarnitine should be taken with food to avoid stomach discomfort. The injectable form of the medicine will be given intravenously (into the vein) by your doctor in the hospital setting. Nucarnit-E 150 mg Capsule should be used with caution if you have diabetes because it can alter the blood glucose levels.
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for Nucarnit-E 150 mg Capsule

  • Allergic reaction
  • Increased blood pressure
  • Increased heartbeat
  • Fever
  • Diarrhoea
  • Nausea or vomiting
  • Dizziness

Uses of Nucarnit-E 150 mg Capsule

What is it prescribed for?

  • Primary systemic carnitine deficiency
  • Secondary carnitine deficiency
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time required for Nucarnit-E 150 mg Capsule to show its effect is not known.
  • How long do the effects of this medicine last?
    The amount of time for which Nucarnit-E 150 mg Capsule remains active in the body is not known.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendency has been reported for Nucarnit-E 150 mg Capsule.
  • Can this medicine be taken during pregnancy?
    Nucarnit-E 150 mg Capsule is considered safe for use in pregnancy. However, discuss all the risks and benefits with your doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    Nucarnit-E 150 mg Capsule is safe to be used during breastfeeding. This medicine is known to pass into breast milk and does not cause harm to your infant. However, inform your doctor if you are breastfeeding before taking this medicine.

Allergy

Do not take Nucarnit-E 150 mg Capsule if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulty, etc.
Warnings for special population

Pregnancy

Nucarnit-E 150 mg Capsule is considered safe for use in pregnancy. However, discuss all the risks and benefits with your doctor before taking this medicine.

Breast-feeding

Nucarnit-E 150 mg Capsule is safe to be used during breastfeeding. This medicine is known to pass into breast milk and does not cause harm to your infant. However, inform your doctor if you are breastfeeding before taking this medicine.
General warnings

Kidney diseases

Nucarnit-E 150 mg Capsule is excreted from the kidneys. If you have kidney problems this medicine may accumulate in your kidneys and leads to serious side effects. Your doctor may adjust the dose of this medicine based on your clinical condition. Nucarnit-E 150 mg Capsule is not recommended for use if you have severe kidney problems.

Other medicines

Nucarnit-E 150 mg Capsule may interact with many other medicines and may cause severe side effects. Hence, inform the doctor about all your concurrent medicines including any herbs and supplements before beginning treatment with Nucarnit-E 150 mg Capsule.

Stomach discomfort

The oral form of Levocarnitine may cause stomach irritation leading to side effects such as nausea, vomiting, stomach pain or cramps. Seek medical help if you notice any of these symptoms.

Missed Dose

Oral forms: If you missed a dose of Nucarnit-E 150 mg Capsule, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not take two doses together to make up for a missed dose. Injection: Since Nucarnit-E 150 mg Capsule is given in the hospital setting by a qualified healthcare professional, the likelihood of missing a dose is very low.

Overdose

Oral forms: Never take more than the prescribed dose of Nucarnit-E 150 mg Capsule. If you suspect that you might have taken an overdose of this medicine, seek immediate medical help. Injection: Since Nucarnit-E 150 mg Capsule is administered by a healthcare professional, the chances of overdose are very less. However, your doctor will take measures if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Anticoagulants

Disease interactions

Diabetes Mellitus

Nucarnit-E 150 mg Capsule may interfere with the insulin secretion in the body and may increase the risk of high blood sugar levels in your body. Consult your doctor if you experience unusual weakness, frequent urination, or any diabetes-associated side effects after taking this capsule.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Oral form: Nucarnit-E 150 mg Capsule should be taken with food or as instructed by your doctor. Never take more than the prescribed dose. Consult your doctor if you experience any undesirable effects. Report all your current medicines as well as your pre-existing medical conditions if any to your doctor before taking Nucarnit-E 150 mg Capsule. Foods containing vitamin C like orange, lemon, kiwi, etc., can increase the carnitine levels in the body. Taking Nucarnit-E 150 mg Capsule along with dairy products may show a faster action. Parenteral form: Nucarnit-E 150 mg Capsule should be given by a qualified healthcare professional in the hospital setting. Inform your doctor if you are on anticoagulant or antidiabetic medications before receiving Nucarnit-E 150 mg Capsule.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Nucarnit-E 150 mg Capsule works by improving the low levels of carnitine in the body. It helps the body produce energy and improves the efficiency of body function.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Intravenous nutritional products, Oral nutritional supplements

Schedule

N/A

Pubchem.ncbi.nlm.nih.gov. 2021. Levocarnitine. [online] Available at: < [Accessed 7 October 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/Levocarnitine>

Pdf.hres.ca. 2021. [online] Available at: < [Accessed 7 October 2021].

https://pdf.hres.ca/dpd_pm/00041980.PDF>

Accessdata.fda.gov. 2021. [online] Available at: < [Accessed 5 July 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/018948s024,019257s011lbl.pdf>

Medicines.org.uk. 2021. Levocarnitine 30% Paediatric Oral Solution - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 5 July 2021].

https://www.medicines.org.uk/emc/product/5140/smpc>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 14 Oct 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.